Quality Assurance at the (Clinical Research) Site: How to Develop a Manageable Plan
Jennifer Holcomb
60 Min
Product Id: 702406
This clinical compliance training will help attendees understand how they can develop and implement a Quality Assurance (QA) program at their clinical research site that ensures the staff are properly trained and that the research is carried out in accordance with regulatory expectations.
Selection and Management of Contract Vendors
Peggy Berry
90 Min
Product Id: 704884
This webinar will discuss approaches to selecting vendors to perform manufacturing and testing activities as well as clinical study activities. The information obtained will enable implementation of an effective vendor selection program and a comprehensive vendor management and oversight program. The webinar will address aspects of requesting bids, performing audits, evaluating risks, and preparing plans and agreements for effective oversight and management.
Submitting FDA Electronic Regulatory Filings - Drug Establishment Registrations and Drug Listings
Camille Davis Thornton
60 Min
Product Id: 703234
This webinar on FDA electronic filings will discuss and provide clarification on the process of submitting drug establishment registration and drug listing information to the FDA using its Electronic Submission Gateway (ESG).
Defining and Managing Protocol Deviation/Violation/Exception
Calin Popa
90 Min
Product Id: 704953
This webinar will teach you how to downsize the risk of noncompliance during the development of a clinical trial by helping you to understand, correct and prevent potential protocol deviations/violations.
Creating Effective SOPs for Regulatory Compliance
Henry Urbach
60 Min
Product Id: 702999
This FDA documentation webinar will explain the regulatory expectations for, and the proper design and maintenance of effective and compliant standard operating procedures (SOPs).
The New EU Clinical Trial Regulation
Robert J Russell
90 Min
Product Id: 703758
This course will present attendees with a clear understanding of the new processes and requirements for EU sponsors of clinical trials as the new regulation is published, rolled-out and implemented by the Member States, the European Medicines Agency and the European Commission.
Investigational Review Board and FDA Warning Letters
Kesley Tyson
60 Min
Product Id: 704786
This training program will identify regulations and guidelines pertaining to institutional review boards. Attendees will learn about the historical events leading up to today’s regulatory framework in clinical research as well as discuss recent ethical issues regarding the IRB. The course will also explore the emergence of IRBs that are not academically affiliated.
Institutional Review Boards (IRBs): The Changing Landscape and the Effect on the Conduct of Clinical Research
Sarah Fowler Dixon
60 Min
Product Id: 703400
This clinical research training will explain the Institutional Review Board (IRB) models. It will discuss the regulatory framework for IRB review including 21 CFR 50, 56 and 45 CFR 46.
Data Management in Clinical Research
Kesley Tyson
60 Min
Product Id: 704768
This training program will identify regulations and guidelines pertaining to data management in clinical research. Attendees will learn to translate the regulations and guidelines into practical application for each stage of the clinical trial: start-up, ongoing study management, and study closure. The program will also discuss the do’s/don’t for data management activities through real-life examples.
How to Build Effective Metrics for Vendor Oversight
Beat Widler
60 Min
Product Id: 704766
This training program will explain what the critical areas and elements of vendor oversight are and how you can set such a system up for yourself at your company.
Understanding and Applying Best Practice Standards When Reviewing Clinical Research Contracts
Jennifer Holcomb
60 Min
Product Id: 704337
This training program will take an in-depth look at various clinical research contracts designed for different purposes. Understanding each type including what is being protected and who is being protected is an important part of ensuring compliant administration and management of clinical research activities. Beyond the legal terms, this course will examine the standards for accredited organizations and best practices for ensuring the broadest protections for study participants.
Risk-Based Monitoring Beyond the RACT
Beat Widler
60 Min
Product Id: 704721
This training program will explain what the strengths and weaknesses of the RACT are and where it should be used with caution. It will also elaborate on what needs to be done to establish a comprehensive risk management approach to support risk-based quality management in clinical trials.
When Studies are Exempted from IND Requirements: Understanding the Criteria and the Consequences
Jennifer Holcomb
60 Min
Product Id: 702345
This Clinical compliance training will review the purpose of INDs and the process for obtaining an IND. Attendees will gain a complete understanding of the criteria for exemption and the impact an exemption has on a study.
FDA Pre-Approval Inspection Readiness: Actionable Steps to Prepare for a BIMO Inspection
Nicole Tesar
60 Min
Product Id: 704640
This 60-minute training program is designed for those working in the field of clinical research either as a sponsor (pharmaceutical/biotech company) or a research site. The session will discuss key FDA inspection terminology, types of BIMO inspections, site inspection procedures, and sponsor inspection procedures. Attendees will understand when an inspection is likely to be scheduled and the current trends in findings.
Effective CDISC Clinical Data Acceptance Testing and Compliance
Sunil Gupta
75 Min
Product Id: 704687
This CDISC training program will enumerate clinical data issues, effective methods and SAS macros to identify data issues, and communicating and monitoring improvements in clinical data issues.
Achieving Research Compliance Through Risk Assessment
Sarah Fowler Dixon
60 Min
Product Id: 704689
This training program will analyze the importance of research risks defined in 21 CFR 50 and 45 CFR 46. It will delve into how research risks affect IRB approval and review based on allowable actions in 21 CFR 50. The program will also discuss the need for indemnification language in consent forms based on risk levels.
FDA IDE: Investigational Device Exemption - What You Need To Know
Kesley Tyson
60 Min
Product Id: 704639
This program will identify regulations and guidelines pertaining to investigational device exemptions. Participants will learn to translate regulations and guidelines into practical application. The program will also discuss the dos/don’ts for conducting device trial activities through real-life examples.
CDISC Cloud Computing in the Pharmaceutical Industry: Paradigm Shift in Project Management, Analysis and Validation
Sunil Gupta
75 Min
Product Id: 704674
This training program will help you better manage projects and offer practical tools to understand data content and quality. Attendees will learn to apply validation methods to reduce time to validate clinical summary tables. Attendees will also learn to apply advanced SAS programming techniques to standardize and automate the validation process.
Pharmaceutical Company Specific Records and Information Management Programs
Charlie Sodano
60 Min
Product Id: 704667
This training program will focus on creating a workable and effective records and information policy. It will also discuss establishing records and information management responsibilities, determining the locations of all information resources, planning long term archiving, and content and records management software considerations and options.
ICH Addendum and its Implication on Clinical Development
Beat Widler
60 Min
Product Id: 704636
This training program will discuss investigator oversight and responsibilities, records management including source data, trial data handling and procedures, quality and risk management, vendor oversight and subcontracting, risk-based monitoring and last but not least root cause analyses in case of non-compliances.







